[1]
Santos, P.A., Flamini, M.E., Mourato, F.A., Lima, F.R., Santos, J.A., Lima, F.F., Albuquerque, E.T., de Freitas, A.C. and Brandão, S.C. 2022. Is a four-week hormone suspension necessary for thyroid remnant ablation in low and intermediate risk patients? A pilot study with quality-of-life assessment. Brazilian Journal of Radiation Sciences. 10, 4 (Dec. 2022), 1–16. DOI:https://doi.org/10.15392/2319-0612.2022.2047.